Detalles de la búsqueda
1.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Lancet Oncol
; 24(6): e270-e283, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269858
2.
Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
Value Health
; 26(2): 234-242, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150999
3.
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report.
Value Health
; 25(9): 1463-1468, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049796
4.
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
Value Health
; 24(8): 1137-1144, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34372979
5.
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection.
BMC Med Res Methodol
; 20(1): 103, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375680
6.
Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma.
Health Qual Life Outcomes
; 18(1): 145, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32430019
7.
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
Future Oncol
; 16(27): 2089-2099, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32938212
8.
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Cancer Immunol Immunother
; 68(4): 609-618, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30721341
9.
Psychometric Properties of EQ-5D-5L Scoring Algorithms for the United Kingdom in Metastatic Merkel Cell Carcinoma.
Value Health
; 22(10): 1170-1177, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563260
10.
Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
Health Qual Life Outcomes
; 17(1): 52, 2019 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917810
11.
Value assessment of immuno-oncology in the treatment of rare tumors in the era of accelerated conditional approvals.
Future Oncol
; 15(35): 4057-4067, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31687852
12.
Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma.
Future Oncol
; 14(3): 255-266, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29219612
13.
Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
Health Qual Life Outcomes
; 15(1): 247, 2017 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29273043
14.
Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm.
Eur Radiol
; 24(7): 1521-8, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816938
15.
Metabolic control of adaptive ß-cell proliferation by the protein deacetylase SIRT2.
bioRxiv
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38464227
16.
Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study.
Oncol Ther
; 11(2): 231-244, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36800099
17.
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
N Engl J Med
; 360(14): 1408-17, 2009 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19339720
18.
Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.
Patient
; 15(6): 691-702, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771392
19.
Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial.
Contemp Clin Trials Commun
; 30: 101021, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387988
20.
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches.
Appl Health Econ Health Policy
; 19(3): 389-401, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33314001